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Background: The exact pathogenesis of medication-related osteonecrosis of the jaw (MRONJ) is still unknown. 
The aim of this paper was to investigate the effects of zoledronic acid and dexamethasone on the early phases of 
socket healing in rats subjected to tooth extractions.
Material and Methods: Thirty male Sprague-Dawley rats were divided into 2 groups: pharmacologically treated 
group (T, n=20) and non-pharmacologically treated group (C, n=10). T group rats received 0.1 mg/Kg of zole-
dronic acid (ZOL) and 1 mg/Kg of dexamethasone (DEX) three times a week for 10 consecutive weeks. C group 
rats were infused with vehicle. After 9 weeks from the first infusion, first maxillary molars were extracted in each 
of the rats. Quantitative macroscopic and microscopic analysis was performed to evaluate socket healing 8 days 
after extraction. 
Results: Pharmacologically treated rats showed significant inhibition of bone remodeling. Connective tissue/al-
veolar bone ratio, osteoclast number and woven bone deposition were significantly reduced in group T compared 
to group C. Conversely, the proportion of necrotic bone was higher in group T compared to group C (0.8% and 
0.3%, respectively. P=0.031). ZOL plus DEX do not cause gross effects on socket healing at a macroscopic level.
Conclusions: Our findings confirmed that exposure to ZOL plus DEX impairs alveolar wound repair. Inhibition of 
osteoclastic resorption of socket walls after tooth extraction and the inability to dispose of the necrotic bone may 
be considered the initial steps of MRONJ onset.
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Introduction
Osteonecrosis of the jaw has an incidence in the gen-
eral population of less than 0.001% (1). However, it in-
creases tremendously in patients treated with high dose 
of antiresorptive and/or antiangiogenetic drugs, where 
the incidence rises to 1-15% (1). This condition, called 
medication-related osteonecrosis of the jaw (MRONJ), 
causes various jaw signs and symptoms, including pain, 
swelling, infection and, in some severe cases, pathologic 
fractures. Among MRONJ local risk factors, dento-al-
veolar surgery, and in particular dental extractions, are 
by far the most important. Indeed a rate ranging from 
52-61% of patients with MRONJ reported tooth extrac-
tion as a precipitating event (2). Zoledronate (ZOL) is 
the antiresorptive agent most frequently associated with 
post extractive MRONJ (3). ZOL is a potent nitrogen-
containing bisphosphonate (BP) used for the treatment 
of lytic lesions in patients affected by multiple myeloma 
and for the management of skeletal-related events as-
sociated with bone metastases. ZOL inhibits bone re-
sorption, increasing bone mineral density and reducing 
fracture risks.
In some oncologic patients such as those affected by 
multiple myeloma, glucocorticoids are used in combina-
tion with ZOL and this association further increases the 
risk of post extractive MRONJ (1). Although the patho-
physiology of post-extractive MRONJ is unclear, many 
hypotheses have been proposed, including suppression 
of bone turnover and an antiangiogenetic effects (4). 
ZOL suppresses bone turnover mainly by decreasing 
activity and osteoclast numbers and possesses an anti-
angiogenic action by inducing capillary reduction and 
inhibition of endothelial vascular growth factors (5).
Several studies have investigated the effects of ZOL 
and dexamethasone (DEX) on extractive socket healing 
in rats (6-12) with observations being made 2 weeks or 
more after tooth extraction, but no data exists for the 
very early phases of the healing process.
The purpose of this experimental study is to quantita-
tively evaluate the effect of zoledronic acid and dexa-
methasone on the early phases of socket healing in rats 
undergone to tooth extractions. 
Material and Methods
-Animals
This study was approved by the Parma University Vet-
erinary Sciences Committee for Ethics and by the Ital-
ian Ministry of Public Health and was planned in accor-
dance with the guidelines for experimental procedures 
found in the Declaration of Helsinki of the World Medi-
cal Association. 
Thirty male adult (5 week old) Sprangue-Dawley rats 
weighing 275 ± 25 grams were employed for the ex-
perimental procedure. Animals were housed in cages in 
groups of 3-4 per cage, in excellent hygienic conditions 
with unlimited access to food and water and maintained 
under artificial 12-hour day-night cycle, in a climate-
controlled environment. They were acclimatized for a 
week before the beginning of the study. 
Rats were randomly subdivided into 2 groups:
• pharmacologically treated group (T): composed of 20 
rats injected with intraperitoneal zoledronic acid (0.1 
mg/Kg in saline) and with intramuscular 1 mg/kg dexa-
methasone 3 times a week for 10 weeks; after 9 weeks 
from the first injection rats in this group were subjected 
to tooth extraction;
• non-pharmacologically treated group (C): composed 
of 10 rats infused with saline with the same volume and 
in the same way, at the same frequency and for the same 
duration of group T rats, and likewise subjected to tooth 
extraction after 9 weeks from the first injection.
The doses and time schedule of drug administration 
were designed according to previous studies in litera-
ture (11,13-15). The study population was asymmetri-
cally distributed foreseeing a higher mortality rate in 
the T group, as observed in a previous pilot study to 
test the protocol and to evaluate laser therapy action on 
extraction socket healing in a MRONJ rat model, the 
results of which were not statistically significant.
-Tooth extraction
Nine weeks after the beginning of the study, rats were 
anesthetized with tiletamine/zolazepam (Zoletil®) and 
subjected to the extraction of both maxillary first mo-
lars by the same experienced physician who was blind 
to the experimental conditions. Surgical procedure du-
ration (starting from the utilization of the first instru-
ment to the end of extraction) and the incidence of tooth 
fracture were recorded as indicators of surgical trauma. 
After surgery, rats were maintained on a liquid diet for 
3 days, and then returned to a standard regimen. On 
day 8 after surgery, all the rats were euthanized, under 
general anaesthesia, with an intravenous administration 
of 3 ml of 100 mM solution of cadmium chloride.
-Clinical assessment
At sacrifice, the maxilla of each animal was excised, 
surgical field was photographed using a Canon EOS 
550D camera (shooting mode M, shutter speed 1/200 
sec, aperture F22, 25 cm of distance from the object). 
Each socket was clinically assessed with the following 
healing grading score:
• grade 1
o socket surface wider than the occlusal area of the sec-
ond maxillary molar 
o dark, rough and irregular appearance of the wound 
surface
• grade 2
o intermediate features between grade 1 and 3
• grade 3
o socket surface smaller than the occlusal area of the 
second maxillary molar
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o clear, smooth and homogeneous appearance of wound 
surface
The final healing score for each rat was calculated as the 
sum of the score of right and left sockets.
The wound area of each socket was measured in pixels 
(pxl) with NIH ImageJ software (version 1.48). Assign-
ment of the score and measurement of wound area were 
performed in a blind fashion by the same calibrated ex-
aminer. 
-Histological assessment 
After clinical examination, the maxilla was immersed 
in a 10% buffered formalin solution and fixed for 
24-48 hours. Subsequently, it was decalcified using 
a 10% EDTA solution (pH 7.4) for about 3 days, and 
transversely cut at the frontal level of extraction. The 
samples were embedded in paraffin tissue blocks from 
which 4-5 µm histological sections were obtained. Each 
section was then stained with haematoxylin-eosin. 
Quantitative histological analysis was performed by the 
same experienced pathologist which was unware of the 
assigned treatment. Images were taken under 4X-10X-
40X magnification using a Nikon Eclipse 80i optical 
microscope, equipped with a Nikon Digital Sight DS-
2Mv camera and connected to NIS Elements F control 
software (Nikon Instruments, Calenzano, Italy). Digital 
images were analysed with NIH ImageJ software (ver-
sion 1.48). 
The quantitative analysis of epithelium, connective tis-
sue, alveolar bone, necrotic bone, periosteal reaction 
and newly-formed woven bone was carried out on hae-
matoxylin-eosin images using the manual point count-
ing technique as described by Vasconcelos et al. (16). 
Firstly, for each rat, the 4X magnification image of the 
whole socket was captured with NIS Elements F using 
the Grab Tool for the acquisition of large images and 
stored in TIFF format. Then using NIH ImageJ soft-
ware a point-grid set at 1500 pixel for area per point 
was superimposed on each image, and each point was 
manually counted according to the matched morpho-
logical structure. Relative (%) values of each morpho-
logical structure were considered. Necrotic bone was 
defined as 8-10 adjacent empty lacunae in the alveolar 
bone (17). The number of osteoclasts, defined as multi-
nucleated cells found in proximity to bone surface (18), 
was counted in each socket analysing images under 10X 
magnification. In order to evaluate vascularisation the 
number of blood vessels in each socket was counted in 
randomly chosen fields, 3 in the bone and 3 in the con-
nective tissue, under 40X magnification. The arithmetic 
mean was calculated for each rat.
-Statistical analysis
Distribution of continuous data was assessed by the 
Skewness and Kurtosis test for normality. Normally 
distributed data were reported as mean and standard 
deviation (SD) and were compared with Student t-test 
for unpaired data; non-normally distributed data were 
reported as median and interquartile range (IQR) and 
were compared with Mann-Whitney U test. Categori-
cal data were reported as frequency and percentage and 
compared with Fischer exact test. Count data were re-
ported as median and IQR and compared with Poisson 
regression. P < .05 defined statistical significance. All 
statistical comparisons were performed with Stata ver-
sion 13.0 (Stata Corp., College Station, TX).
Results
-Clinical assessment
Animals well tolerated drug administrations, anaesthe-
sia and tooth extractions, but 3 rats (1 rat in the C group 
and 2 rats in the T group) died before the end of the 
experiment for unknown reasons.
The elapsed time for tooth extraction, the frequency 
of root fractures, average wound area and the healing 
grading score showed no significant differences be-
tween the two groups (Table 1). 
-Histologic assessment 
Five specimens from the T group were excluded from 
the final analysis due to technical problems with his-
tology, mainly due to the cutting phase. Representative 
histologic sections of socket healing 8 days after tooth 
extraction are shown in Figure 1 and quantitative histo-
logical analysis is summarized in Table 2. Rats exposed 
to zoledronic acid plus dexamethasone showed a strong 
inhibition of the physiological process of bone remod-
eling which was observed in C group rats. Indeed, a 
significantly higher proportion of connective tissue was 
found in non-pharmacologically treated rats compared 
to pharmacologically treated ones (48.7 % and 24.8 %in 
group C and T, respectively. P<0.001).
Conversely, a significantly higher proportion of alveolar 
Control Treatment P
Time of Surgery (sec), median (IQR) 132 (90.5 – 154.5) 119 (93 – 258.5) 0.812
Root fractures, n (%) 7 (70) 15 (78.9) 0.665
Area tot (pixels x 104), mean ± SD 14.6±6.9 12.6±4.6 0.392
Healing score, median (IQR) 4 (3 – 5) 4 (4 – 5) 0.916
Table 1. Indicators of surgical trauma and clinical assessment.
IQR = interquartile range.
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Fig. 1. Representative histologic sections to illustrate microscopic features of socket healing 8 days after tooth extrac-
tion. Group C rats showed normal bone remodeling with extensive bone resorption of socket margins (C). Group T rats 
showed marked inhibition of bone remodeling with almost no bone resorption (T). (H&E, original magnification 4X).
Control Treatment P
Epithelium (% total area), mean ± SD 7.0±2.8 7.8±1.4 0.359
Connective tissue (% total area), mean ± SD 48.7±7.8 24.8±4.1 <0.001
Periostial reaction (% total area), mean ± SD 7.2±4.9 1.8±1.8 0.002
New formed bone (% total area), median (IQR) 2.4 (0.7 – 2.8) 0 (0 – 0) <0.001
Necrotic bone (% total area), mean ± SD 0.3±0.4 0.8±0.6 0.031
Alveolar bone (% total area), mean ± SD 31.1±9.7 60.0±6.6 <0.001
Osteoclasts (total number), median (IQR) 24 (19 – 28) 0 (0 – 0) <0.001
Vessels (number/field), median (IQR)
 bone 3.5 (3 – 4) 3 (2 – 4.3) 0.612
connective tissue 4.3 (3.8 – 5.1) 4 (3.3 – 5) 0.645
Table 2. Quantitative histological analysis.
IQR = interquartile range.
bone was observed in rats from the T group compared 
to non-pharmacologically treated ones (60.0 % and 31.1 
% in group T and C, respectively. P<0.001). 
The osteoclast count was significantly higher in rats 
from group C compared to group T (P<0.001). 
Pharmacologically treated rats showed a significant re-
duction in deposition of subperiosteal woven bone on 
the buccal surface of the socket (periosteal reaction). 
Similarly, the deposition of newly-formed woven bone 
inside the socket was reduced in group T compared to 
group C.
Small areas of necrotic bone actively resorbed by os-
teoclasts were present in group C specimens. In some 
cases necrotic bone was set free from the underlying 
vital bone and sloughed into the socket to be expelled as 
bone sequestra (Fig. 2).
Areas of necrotic bone which were not lined by osteo-
clasts were observed in specimens from group T and, 
in half of the microscopic samples, the epithelium was 
ulcerated with exposition of the necrotic bone (Fig. 3). 
The proportion of necrotic bone was significantly high-
er in group T compared to group C (0.8% and 0.3%, 
respectively. P=0.031)
No significant differences were found in terms of pro-
portion of epithelium and number of blood vessels in the 
bone and connective tissue. 
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Fig. 2. Necrotic bone actively resorbed by lining osteoclasts and ex-
pelled from the socket as bone sequestrum in a C group rat (H&E, 
original magnification 4X,10X and 40X).
Fig. 3. Exposed necrotic bone observed in a group T rat (H&E, origi-
nal magnification 4X and X10).
Discussion
This experimental study confirmed the impairment 
effects of zoledronic acid plus dexamethasone on the 
early phases of socket healing after extraction in rats. 
The normal healing process of the extractive socket 
has been extensively studied in rodents (19). In normal 
conditions, the blood clot is replaced by a richly-vas-
cularized granulation tissue while intense osteoclas-
tic bone resorption occurs at the socket margins and 
the alveolar crest. Necrotic bone and bone debris are 
resorbed in this phase. Simultaneously, osteoblast dif-
ferentiation and proliferation lead to initial woven bone 
deposition in the apical and lateral regions. A widening 
of the residual alveolar ridge is often present because 
of the deposition of subperiosteal woven bone on the 
buccal maxillary surface. Bone deposition continues 
until connective tissue within the socket is entirely sub-
stituted by immature mineralized tissue. These features 
were consistently present in specimens obtained from 
non-pharmacologically treated rats. By contrast, phar-
macologically treated rats showed a strong inhibition of 
osteoclastic bone resorption. Toxic effects of nitrogen-
containing bisphosphonates (e.g. zoledronic acid) on 
osteoclasts are well documented and include changes 
in the cytoskeleton, loss of raffled border, disruption of 
actin rings and altered vesicular trafficking, leading to 
their inactivation and potential apoptosis (20). These ef-
fects are mainly due to inhibition of farnesyl pyrophos-
phate synthase, an enzyme of the mevalonate biosyn-
thetic pathway (20). In rats exposed to zoledronic acid 
the osteoclast count was significantly lower compared 
to non-exposed rats causing a reduction in alveolar bone 
resorption. Indeed, the alveolar bone/connective tissue 
ratio was reversed when comparing pharmacologically 
and non-pharmacologically treated rats, with the latter 
showing a higher proportion of connective tissue over 
bone. 
The above reported inhibition of bone resorption could 
be due not only to zoledronic acid exposure, but also to 
DEX. While humans exposed to glucocorticoids exhibit 
elevated bone resorption, the same drugs in rats cause 
osteoclast apoptosis (21). Byers et al. demonstrated a 
10-fold reduction in the number of alveolar osteoclasts 
in rats exposed to daily dexamethasone (0.2mg/Kg) ad-
ministred for 1 week (22). Hence it is likely that dexa-
methasone contributed to the inhibition of osteoclastic 
resorption observed in group T. 
When alveolar bone is exposed after tooth extraction, 
tissues react forcefully in order to prevent osteomyelitis 
and osteonecrosis. This is due to the fact that exposed 
bone has no mechanism for dealing with inevitable bac-
terial colonization of the mineralized surface. Therefore, 
before regeneration, the exposed bone is undermined by 
osteoclastic resorption, leaving a soft connective-tissue 
surface that can defend against bacterial invasion. This 
was observed in rats from group C. In rats from group 
T zoledronate plus dexamethasone prevent undermin-
ing and disposal of necrotic bone by osteoclasts. The in-
ability of the alveolus to dispose of necrotic bone could 
then lead to osteonecrosis development. Indeed, many 
studies have shown the onset of MRONJ-like lesions af-
ter tooth extraction in rats treated with zoledronic acid 
and dexamethasone (6-11,23). In our study MRONJ-like 
lesions were not observed, due to the insufficient obser-
vation time (8 days) after surgery which was not long 
enough for the development of a frank osteonecrosis.
Pharmacologically treated rats showed a reduction in 
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deposition of newly formed woven bone at the bottom 
of the socket and of subperiosteal woven bone on the 
buccal surface of the socket (periosteal reaction) com-
pared to controls. Osteoclasts are the main targets of 
bisphosphonates, but these drugs can exert biological 
effects on other cell populations, including osteoblasts. 
Basso et al. observed a highly cytotoxic effect on os-
teoblasts treated with zoledronic acid, characterized by 
decreased viability, total protein production and min-
eral nodule formation (24). Similar results were found 
by other authors (25). The relationship between dexa-
methasone and bone deposition is more complex: while 
it is well documented that corticosteroids can promote 
osteoblast differentiation (26), some studies have re-
ported an inhibitory effect of dexamethasone on bone 
formation presumably mediated by glucocorticoid re-
ceptors, which have been demonstrated to be present in 
osteoblasts (27,28). 
Inhibition of angiogenesis has been proposed as a pos-
sible mechanism of MRONJ pathophysiology (2). How-
ever, we did not observe a significant difference in 
terms of blood vessel numbers in the bone and in the 
connective tissue between groups C and T. Our findings 
are consistent with the study of Sonis et al. where no 
differences in vascularity were seen between controls 
and ZOL+DEX-treated animals (11). 
We found that rats treated with zoledronic acid and 
dexamethasone did not show a delayed healing at mac-
roscopic level compared to the controls. This contrasts 
with others studies on rat models in which gross differ-
ences of socket healing were found due to BP admin-
istration (7,8,10-12,29). A possible explanation could 
be that in our protocol rats were sacrificed 8 days after 
tooth extraction, while in the aforementioned studies 
macroscopic evaluation was performed after 14 days or 
later. It is reasonable to think that macroscopic impair-
ing effects of medication could be more evident in the 
later phases of socket healing. We chose a short post-
operative observation time to investigate the possible 
effects of ZOL plus DEX on the early phases of healing 
processes.
Indicators of surgical trauma (extraction time and 
frequency of root fractures) did not differ among the 
groups. According to this data it is possible to exclude 
differences in socket healing due to a different distribu-
tion of surgical stress between groups C and T. 
The major limitation of our study was that we didn’t 
use immunohistochemical assays to investigate the vas-
colarization and the number of osteoclasts. We chose 
traditional and less sophisticated methods for histomor-
phometrical analysis because this was a preliminary 
study, whose results would help us to plan future exper-
iments with more sensitive techniques. Another limita-
tion was the lack of a group treated only with ZOL and 
of a group treated only with DEX in order to compare 
the single medication with the ZOL+DEX combination. 
We choose to limit the group number and, consequently, 
the number of sacrificed rats for ethical and economical 
issues.
Our study confirmed the impairing of socket healing 
caused by zoledronic acid and dexamethasone allowing 
us to detect early microscopic alterations that represent 
the initial steps towards MRONJ onset. 
Since MRONJ is a severe condition causing a consider-
able burden for patients and clinicians, further in vivo 
research on animal models is needed to better clarify 
the pathogenetic mechanism of MRONJ in order to 
elaborate effective preventive strategies.
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